One of the biggest meetings of the world’s cancer specialists took place this weekend. Usually located in Chicago, researchers and clinicians around the world met virtually this year to present the latest in cancer research at the American Society of Clinical Oncology (ASCO) annual meeting. Here’s a flavour of the some of the top research presented.
An existing combination of chemotherapy could be used to provide a new option for biliary tract cancer patients.
The first proton beam therapy clinical trial in the UK is finding out if this innovative new form of radiotherapy can improve throat cancer treatment.
People with an aggressive form of lung cancer that’s come back after treatment could live longer when treated with the immunotherapy drug nivolumab.
A new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer.
As coronavirus cases continue to rise in the UK, we look at how cancer clinical trials have been affected by the pandemic.
Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer.
The National Lung Matrix Trial – a £25 million collaboration with pharmaceutical companies and the NHS – has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.
Cancer Research UK’s calls backed by eminent Edinburgh scientist who says the COVID-19 halt to clinical trials has taken away hope for some patients.
New clinical trial results show that adding rituximab to standard chemotherapy could improve survival for some children with non-Hodgkin lymphoma.